determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

1.1 Žilní trombembolismus Cílová hodnota INR u první epizody žilního trombembolismu má
být 2, 5. V úvodu léčby se má současně s užíváním warfarinu zahájit také parenterální …

Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Background This guideline addresses the management of patients who are receiving
anticoagulant or antiplatelet therapy and require an elective surgery or procedure. Methods …

Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical
patients is largely underused. We sought to assess the value of a simple risk assessment …

Background About 20% of patients with unprovoked venous thromboembolism have a
recurrence within 2 years after the withdrawal of oral anticoagulant therapy. Extending …

Document Reviewers: Jose-Luis Zamorano,(CPG Review Coordinator)(Spain), Felicita
Andreotti (Italy), Michael Ascherman (Czech Republic), George Athanassopoulos (Greece) …

The periprocedural management of patients receiving long-term oral anticoagulant therapy
remains a common but difficult clinical problem, with a lack of high-quality evidence to inform …

Background—Predicting the risk of recurrent venous thromboembolism (VTE) in an
individual patient is often not feasible. We aimed to develop a simple risk assessment model …